Hoth Therapeutics Files 2023 Annual Report

TL;DR

Hoth Therapeutics filed its 2023 10-K. Check financials for the year ending Dec 31.

AI Summary

Hoth Therapeutics, Inc. filed its annual report for the fiscal year ended December 31, 2023. The company, incorporated in Nevada, operates in the Pharmaceutical Preparations sector. Its principal executive offices are located at 590 Madison Avenue, New York, NY. The filing details the company's business, financial condition, and results of operations for the year.

Why It Matters

This 10-K filing provides a comprehensive overview of Hoth Therapeutics' financial health and operational performance for the past fiscal year, crucial for investors and stakeholders to assess the company's trajectory.

Risk Assessment

Risk Level: medium — As a pharmaceutical company, Hoth Therapeutics faces inherent risks related to drug development, regulatory approvals, and market competition, which are detailed in its 10-K filing.

Key Players & Entities

• Hoth Therapeutics, Inc. (company) — Registrant
• December 31, 2023 (date) — Fiscal year end
• 590 Madison Avenue, 21st Floor, New York, NY 10022 (location) — Principal executive offices
• Nevada (location) — State of incorporation
• 001-38803 (other) — Commission file number

FAQ

From the Filing

0001213900-24-027213.txt : 20240328 0001213900-24-027213.hdr.sgml : 20240328 20240328160739 ACCESSION NUMBER: 0001213900-24-027213 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 76 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240328 DATE AS OF CHANGE: 20240328 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hoth Therapeutics, Inc. CENTRAL INDEX KEY: 0001711786 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 821553794 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38803 FILM NUMBER: 24798888 BUSINESS ADDRESS: STREET 1: 590 MADISON AVENUE STREET 2: 21ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (646)756-2997 MAIL ADDRESS: STREET 1: 590 MADISON AVENUE STREET 2: 21ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 10-K 1 ea0202303-10k_hoth.htm ANNUAL REPORT     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 10-K   ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   For the fiscal year ended December 31 , 2023   ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   For the transition period from ______ to ______   Commission file number 001-38803   HOTH THERAPEUTICS, INC. (Exact name of registrant as specified in charter)   Nevada   82-1553794 (State or other jurisdiction of incorporation or organization)   I.R.S. Employer Identification No.   590 Madison Ave , 21 st Floor , New York , New York   10022 (Address of principal executive offices)   (Zip code)   (646) 756-2997 (Registrant’s telephone number, including area code)   Securities registered pursuant to Section 12(b) of the Act:   Title of Each Class   Trading Symbol(s)   Name of Each Exchange on Which Registered Common Stock, par value $0.0001 per share   HOTH   The Nasdaq Stock Market LLC   Securities registered pursuant to Section 12(g) of the Act: None.   Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒   Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒   Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐   Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐   Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.   Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company   ☒     Emerging growth company ☒   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of t